Explore the vast range of titles available.

This article presents the accurate and current state of knowledge regarding the process of angiogenesis in neoplastic cells and its importance for tumour development. It provides a detailed review of the different types of angiogenesis with a brief discussion of individual angiogenic factors. Pathological angiogenesis in tumour tissues and the production of angiogenic factors have been recognised as key features responsible for cancerous development and distant metastasis formation since 1971. A phenomenon known as an angiogenic switch allows neoplasm to transform from an avascular to a vascular phase. The emerging new network of blood vessels allows cancer cells to efficiently exchange gases, provide nutrients and eliminate metabolic waste products. The main factors stimulating the angiogenesis process are VEGF, FGF, EGF, PDGF, and TGF-β1. To date, the most specific, strongest and most widely studied factor is VEGF. It is regarded as the main mitogen for vascular endothelial cells, stimulating their proliferation, and it is therefore referred to as a survival factor for cancer cells. Several mechanisms of new blood-vessel formation in cancerous tissue have also been identified. The three dominant processes include vascular sprouting, intussusceptive angiogenesis and vessel co-option. Angiogenesis in cancer tissues remains a subject of numerous scientific studies. A thorough understanding of the mechanism of oncogenesis and tumour expansion appears to be the starting point for future research aimed at finding effective anti-cancer therapy.

The aim of the experiment was to study the morphology of collagen-based scaffolds modified by caffeic acid, ferulic acid, and gallic acid, their swelling, and degradation rate, as well as the biological properties of scaffolds, such as antioxidant activity, hemo- and cytocompatibility, histological observation, and antibacterial properties. Scaffolds based on collagen with phenolic acid showed higher swelling rate and enzymatic stability compared to scaffolds based on pure collagen, and the radical scavenging activity was in the range 85–91%. All scaffolds were non-hemolytic and compatible with surrounding tissues. Collagen modified by ferulic acid showed potentially negative effects on hFOB cells as a significantly increased LDH release was found, but all of the studied materials had antimicrobial activity against Staphylococcus aureus and Escherichia coli . It may be assumed that phenolic acids, such as caffeic, ferulic, and gallic acid, are modifiers and provide novel biological properties of collagen-based scaffolds. This paper provides the summarization and comparison of the biological properties of scaffolds based on collagen modified with three different phenolic acids.

Two types of thin films differing in thickness and morphology of microporous CN‐bridged hybrid organic–inorganic [NiII(cyclam)]3[MIII(CN)6]2∙nH2On (M = Cr or Fe, cyclam = 1,4,7,11‐tetraazacyclotetradecane) coordination networks are obtained by using physical and chemical deposition techniques. By adsorption on the PET/ITO substrate of the pre‐formed nano‐sized crystallites from water suspension, films of 1–2 µm thickness composed of 40–200 nm size particles are obtained. The use of chemical sequential growth method, in which the coordination framework is anchored to the gold surface and built directly on the substrate from the cationic and anionic building blocks, reduces the film thickness to 100 nm and drastically improves film morphology. Both types of thin films show solvatomagnetic behavior characteristic for bulk compounds and change magnetic characteristics, including the shape of the magnetic hysteresis, under different humidity conditions. Hybrid organic–inorganic CN‐bridged coordination polymers can be prepared as thin films of micro‐ or nanoscale thickness by deposition of pre‐formed crystallites or in situ formation of the network on the substrate surface in sequential growth. Both forms of films retain solvatomagnetic characteristics of the bulk compounds changing magnetic properties upon inclusion/removal of guest water molecules.

Similarly, in humans and horses, thoracic and lumbosacral back pain cause more disability and work interruptions worldwide than any other disease. Given that there are few effective treatments for back pain in humans and animals, primary prevention strategies and a reduction in pain factors may be crucial. In the analysed data obtained for the horses studied, the pattern of changes in adipocytokine concentrations, including resistin, visfatin and leptin, was noted for those with back pain compared to the control animals. Concentrations of selected adipocytokines in horses from the back pain group were different in animals with a coexisting diagnosis of asthma and back dysfunction. Very few studies are available on adipokine concentrations in horses. No information was found in relation to back pain and asthma in these animals. In humans, correlations of back pain and asthma with concentrations of selected adipokines have been described.

Stem cells are widely used in regenerative medicine and in clinical practice for the treatment of damaged nerve tissue, myocytes, tendons, and ligaments. The aim of the study was to monitor VEGF levels after the administration of allogenic cellular material (SVF) in the course of treatment of dogs suffering from degenerative joint disease in the spinal region. The study was conducted on 10 dogs of both genders, aged between 6 and 13 years in which allogenic stromal vascular fraction of stem cells (SVF) was administered intravenously. The control group was composed of 10 clinically healthy dogs. Before treatment and after 2- and 8-week intervals blood samples were obtained from the study group dogs in order to determine VEGF levels via immunoenzymatic test. in a few days after the therapy, alleviation of pain symptoms and reduction of lameness were noticed. The VEGF level in 2 weeks after the therapy was significantly elevated (median: 38.77 pg/ml), while in 8 weeks a decrease was observed (median: 18.37 pg/ml). Conlusion: Administration of allogenic stem cells has a positive influence on elevation of the VEGF levels in the blood serum of affected animals as well as their regeneration capacity.

Canine periodontitis results among other factors from a disturbed balance of dental plaque microflora and an inadequate host inflammatory response to a stimulus. This investigation sought to identify microorganisms associated with canine periodontitis. Microbiological analysis was undertaken of gingival pockets in an experimental group of 36 dogs with periodontal diseases. Swabs were collected with the use of Pet Test (MIP Pharma, Berlin, Germany) from patients with gingival pockets deeper than 5 mm. Samples were aggregated and placed in separate shipping containers with the Pet Test kit. Identification was made of the most common microorganisms, . , and . The red complex constituted the largest proportion of all analysed organisms (84.26%). was isolated from 33 dogs, from 32 dogs, from 29 animals and from 20. The highest percentage of pathogens was supplied by (61%). It is thought that dogs acquire them by means of cross-species transmission. The inter-study variability of results may depend not only on the method of periopathogen detection, but also on environmental factors, host immune status or genetic background. Depending on the state of periodontal disease, patients show varied microbiological profiles of the gingival pockets.

Gastrointestinal mycobacteriosis in horses is difficult to diagnose because of the pathogen’s intracellular nature and the non-specific clinical symptoms. Effective accurate diagnosis facilitates prognosis and treatment. Current diagnostic procedures and methods of collecting material do not permit definitive antemortem diagnosis. However, culturing, acid-fast bacilli staining, histopathology, PCR and immunological marker evaluation may prove useful. Three horses were admitted to a clinic for intensive care and a final diagnosis. Physical examination and additional tests were performed. Unfavourable prognoses and lack of treatment response prompted euthanasia decisions. Necropsy was performed, as were histological, microbiological and molecular investigations. The clinical condition of the animals deteriorated despite therapy. Two horses were euthanised when they did not respond to treatment and had poor prognoses. Intestinal mycobacteriosis caused by Mycobacterium avium subsp. hominissuis was diagnosed postmortem using laboratory investigations. One horse’s diagnosis was established antemortem by cytological and microbiological examination of biopsy material from an abdominocentesis, and this animal was also euthanised because of its poor prognosis. Mycobacteriosis should be considered in the differential diagnosis of chronic debilitating equine diarrhoea in addition to rhodococcosis, lawsoniosis, salmonellosis, gastric ulcers and food intolerance. Peritoneal fluid obtained by abdominocentesis proved to be an effective diagnostic method for microbiological and molecular identification of Mycobacterium avium subsp. hominissuis in horses with suspected enteric mycobacteriosis and concomitant ascites.

Chitosan-based scaffolds modified by gallic acid, ferulic acid, and tannic acid were fabricated. The aim of the experiment was to compare the compatibility of scaffolds based on chitosan with gallic acid, ferulic acid, or tannic acid using the in vivo method. For this purpose, materials were implanted into rabbits in the middle of the latissimus dorsi muscle length. A scaffold based on unmodified chitosan was implanted by the same method as a control. Moreover, the Fourier transform infrared spectroscopy-attenuated total reflectance (FTIR-ATR) spectra and scanning electron microscope (SEM) observations were made to study the interactions between chitosan and phenolic acids. Additionally, antioxidant properties and blood compatibility were investigated. The results showed that all studied materials were safe and non-toxic. However, chitosan scaffolds modified by gallic acid and tannic acid were resorbed faster and, as a result, tissues were organized faster than those modified by ferulic acid or unmodified.

The 1D [CuII(cyclam)]3[WV(CN)8]2.5H2On (1·5H2O) (cyclam = 1,4,8,11-tetraazacyclotetradecane) coordination polymer of ladder topology can be obtained in water-alcohol solution from [Cu(cyclam)]2+ and [W(CN)8]3− building blocks. Upon dehydration, 1·5H2O undergoes a single-crystal-to-single-crystal structural transformation to the anhydrous [CuII(cyclam)]3[WV(CN)8]2n (1) form, which retains the same topology, but is characterized by shorter Cu-W distances and significantly more bent CN-bridges. The deformation of the coordination skeleton is reflected in magnetic properties: the predominant intra-chain interactions change from ferromagnetic in 1·5H2O to antiferromagnetic in 1. The reaction between the same building blocks in water solution under slow diffusion conditions leads to the formation of a 0D [CuII(cyclam)(H2O)]2[CuII(cyclam)][WV(CN)8]2.3H2O pentanuclear assembly (2·3H2O).

HIV-1 maturation inhibitors (MIs) disrupt the final step in the HIV-1 protease-mediated cleavage of the Gag polyprotein between capsid p24 capsid (CA) and spacer peptide 1 (SP1), leading to the production of infectious virus. BMS-955176 is a second generation MI with improved antiviral activity toward polymorphic Gag variants compared to a first generation MI bevirimat (BVM). The underlying mechanistic reasons for the differences in polymorphic coverage were studied using antiviral assays, an LC/MS assay that quantitatively characterizes CA/SP1 cleavage kinetics of virus like particles (VLPs) and a radiolabel binding assay to determine VLP/MI affinities and dissociation kinetics. Antiviral assay data indicates that BVM does not achieve 100% inhibition of certain polymorphs, even at saturating concentrations. This results in the breakthrough of infectious virus (partial antagonism) regardless of BVM concentration. Reduced maximal percent inhibition (MPI) values for BVM correlated with elevated EC50 values, while rates of HIV-1 protease cleavage at CA/SP1 correlated inversely with the ability of BVM to inhibit HIV-1 Gag polymorphic viruses: genotypes with more rapid CA/SP1 cleavage kinetics were less sensitive to BVM. In vitro inhibition of wild type VLP CA/SP1 cleavage by BVM was not maintained at longer cleavage times. BMS-955176 exhibited greatly improved MPI against polymorphic Gag viruses, binds to Gag polymorphs with higher affinity/longer dissociation half-lives and exhibits greater time-independent inhibition of CA/SP1 cleavage compared to BVM. Virological (MPI) and biochemical (CA/SP1 cleavage rates, MI-specific Gag affinities) data were used to create an integrated semi-quantitative model that quantifies CA/SP1 cleavage rates as a function of both MI and Gag polymorph. The model outputs are in accord with in vitro antiviral observations and correlate with observed in vivo MI efficacies. Overall, these findings may be useful to further understand antiviral profiles and clinical responses of MIs at a basic level, potentially facilitating further improvements to MI potency and coverage.